EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access

Triptan Initiation and Cerebrovascular Events in Patients With Migraine: A Nationwide Cohort Study

Cheryl Kalapura iD, Jay B Lusk iD, Lauren E Wilson iD, Carlene Moore iD, Stephanie Yarnell, Aparna Choudhury, Matthew Schrag iD, Sven Poli iD, Nosayaba Osazuwa-Peters, Emily O'Brien iD, Eric D Peterson iD, Ying Xian iD und 2 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.043409 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Cheryl Kalapura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine Durham NC USA. Hauptthemen laut MEDLINE: Migraine Disorders, Tryptamines, Ischemic Stroke, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Triptan medications are proposed as an association of cerebral ischemic stroke in patients with migraine, but population‐based data on this are lacking.

Methods

A retrospective, observational, cohort study was performed using computerized claims data from a proprietary, insurance‐based registry—Marketscan (by Merative). Patients with at least 1 claim related to a migraine diagnosis were included. The primary exposure was initiation of any triptan medication defined by at least 1 prescription fill. The primary end point was time to cerebral ischemic stroke. Secondary end points included time to retinal stroke (central retinal artery occlusion, other retinal artery occlusion), intracranial hemorrhage, and myocardial infarction. The association between triptan initiation and study end points was modeled using a propensity score‐overlap weighted Cox model. Adjusted hazard ratios (HR) and corresponding 95% CIs were computed.

Results

In total, 869 092 patients (median age 40.0 years [Q1–Q3, 30.0–50.0]; 77.5% female) met study selection criteria of whom 287 629 initiated a triptan and 581 463 did not. Median follow‐up was 2555 days in the entire cohort. Initiation of a triptan was associated with higher hazard of cerebral ischemic stroke (adjusted HR, 2.37 [95% CI, 1.65–3.51]; absolute risk difference of 0.17% per year). Of 4 secondary end points, 2 were associated with triptan use: intracranial hemorrhage (adjusted HR, 2.37 [95% CI, 1.65–3.41]) and myocardial infarction (adjusted HR, 2.06 [95% CI, 1.60–2.66]).

Conclusions

In a population‐based cohort study, initiation of a triptan was independently associated with risk of subsequent cerebral ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersTryptaminesIschemic StrokeStrokeHumansFemaleRetrospective StudiesMaleMiddle AgedAdultRisk FactorsRegistriesIntracranial HemorrhagesTime FactorsProportional Hazards ModelsMyocardial InfarctionPropensity Score

Stichwörter der Autor:innen

cerebrovascular diseaseintracranial hemorrhagemigrainestroketriptan

Substanzen

Tryptamines

Autor:innen und Institutionen

  • Duke University School of Medicine Durham NC USA.
  • Department of Family Medicine University of North Carolina Chapel Hill Chapel Hill NC USA.
  • ORBIT Interdisciplinary Hub, Duke Clinical Research Institute Duke University Durham NC USA.
  • Department of Neurology Duke University School of Medicine Durham NC USA.
  • Department of Population Health Sciences Duke University School of Medicine Durham NC USA.
  • Department of Psychiatry Yale University School of Medicine New Haven CT USA.

ORCID-Profile: Cheryl Kalapura, Jay B Lusk, Lauren E Wilson, Carlene Moore, Matthew Schrag, Sven Poli, Emily O'Brien, Eric D Peterson, Ying Xian, Fan Li, Brian Mac Grory

Zitieren

APA

Kalapura, C., Lusk, J. B., Wilson, L. E., Moore, C., Yarnell, S., Choudhury, A., Schrag, M., Poli, S., Osazuwa-Peters, N., O'Brien, E., Peterson, E. D., Xian, Y., Li, F., & Mac Grory, B. (2026). Triptan Initiation and Cerebrovascular Events in Patients With Migraine: A Nationwide Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043409

Vancouver

Kalapura C, Lusk JB, Wilson LE, Moore C, Yarnell S, Choudhury A, et al. Triptan Initiation and Cerebrovascular Events in Patients With Migraine: A Nationwide Cohort Study. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.043409

BibTeX
@article{Kalapura2026,
  author = {Kalapura, Cheryl and Lusk, Jay B and Wilson, Lauren E and Moore, Carlene and Yarnell, Stephanie and Choudhury, Aparna and Schrag, Matthew and Poli, Sven and Osazuwa-Peters, Nosayaba and O'Brien, Emily and Peterson, Eric D and Xian, Ying and Li, Fan and Mac Grory, Brian},
  title = {Triptan Initiation and Cerebrovascular Events in Patients With Migraine: A Nationwide Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.043409}
}
Kostenlos starten →